Should we abandon the APTT for monitoring unfractionated heparin?

Arachchillage, D R J; Kamani, F; Deplano, S; Banya, W; Laffan, M

Arachchillage, D R J; Kamani, F; Deplano, S; Banya, W; Laffan, M.

Afiliación

Arachchillage DRJ; Department of Haematology, Royal Brompton & Harefield NHS Foundation Trust, London, UK; Department of Haematology, Imperial College Healthcare NHS Trust and Imperial College London, London, UK. Electronic address: d.arachchillage@imperial.ac.uk.
Kamani F; Department of Haematology, Royal Brompton & Harefield NHS Foundation Trust, London, UK.
Deplano S; Department of Haematology, Royal Brompton & Harefield NHS Foundation Trust, London, UK.
Banya W; Department of Haematology, Royal Brompton & Harefield NHS Foundation Trust, London, UK.
Laffan M; Department of Haematology, Imperial College Healthcare NHS Trust and Imperial College London, London, UK.

Thromb Res ; 157: 157-161, 2017 Sep.

Article en En | MEDLINE | ID: mdl-28759760

Asunto(s)

Heparina de Bajo-Peso-Molecular/uso terapéutico; Tiempo de Tromboplastina Parcial/métodos; Femenino; Humanos; Masculino

Palabras clave

Activated partial thromboplastin time; Anti-Xa; Concordance; Fibrinogen; Heparin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiempo de Tromboplastina Parcial / Heparina de Bajo-Peso-Molecular Límite: Female / Humans / Male Idioma: En Revista: Thromb Res Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google